Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Clinical Trial ID NCT02485652

Rank	Title	Journal	Year	PubWeight™‹?›
1	Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC.	Front Oncol	2016	0.79